Related Experiment Videos
Nuclear membrane-staining antinuclear antibody in patients with primary biliary cirrhosis
Abstract:
An antinuclear antibody specific for nuclear membrane (ANMA) was observed by the immunofluorescence method in sera from patients with primary biliary cirrhosis (PBC). ANMA was present in 18 of 63 PBC sera (28.5) and in 1 of 431 control sera (0.2%). Its reaction appeared as a thin fluorescent ring confined to the nuclear envelope and was more evident when the sera were highly diluted and the fluorescence, due to frequently associated antimitochondrial antibody, faded. The ANMA fluorescent pattern was confirmed by indirect immunoperoxidase staining. ANMA was seen on both tissue cryostat sections and HEp-2 cells. It was a poorly or non-complement-fixing IgG, specific for an antigen resistant to DNase I, RNase, and trypsin. The significance of its presence in PBC in unknown at present. Identification of its antigen with one of the centromeric antigens is suggested.
Insights
Researchers identified a novel antinuclear antibody specific for nuclear membrane (ANMA) in primary biliary cirrhosis (PBC) patients. This ANMA marker was found in 28.5% of PBC cases, suggesting a potential role in the autoimmune liver disease.
Area of Science:
- Immunology
- Hepatology
- Autoimmunity
Background:
- Primary biliary cirrhosis (PBC) is a chronic autoimmune liver disease.
- Autoantibodies play a crucial role in the pathogenesis and diagnosis of autoimmune diseases.
- Specific autoantibodies are often associated with PBC, aiding in its diagnosis.
Purpose of the Study:
- To identify and characterize a novel antinuclear antibody (ANMA) in patients with primary biliary cirrhosis (PBC).
- To determine the prevalence of ANMA in PBC patients compared to a control group.
- To investigate the properties and potential significance of ANMA in PBC.
Main Methods:
- Immunofluorescence method was used to detect ANMA in patient sera.
- Indirect immunoperoxidase staining confirmed the ANMA fluorescent pattern.
- ANMA was tested on tissue cryostat sections and HEp-2 cells.
- Antibody properties including complement fixation and antigen resistance were assessed.
Main Results:
- ANMA was detected in 18 out of 63 (28.5%) PBC sera, but only in 1 out of 431 (0.2%) control sera.
- The ANMA reaction presented as a distinct ring confined to the nuclear envelope.
- ANMA was identified as a poorly or non-complement-fixing IgG antibody.
- The target antigen was resistant to DNase I, RNase, and trypsin digestion.
Conclusions:
- A novel antinuclear antibody specific for the nuclear membrane (ANMA) is frequently observed in patients with primary biliary cirrhosis (PBC).
- The high specificity of ANMA for PBC warrants further investigation into its diagnostic and pathogenetic significance.
- Further research is needed to identify the specific antigen targeted by ANMA and its relationship to other known autoantigens.